About
CAR engineered gammadelta cells
Areas of Focus
Categories
Stem Cell & Cellular TherapySingapore
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
134
By Phase
PHASE1: 4
By Status
UNKNOWN: 3RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05302037Lead Sponsor
Allogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers (ANGELICA)
PHASE1Recruiting
12 participants
Started: Nov 19, 2024 · Completed: Dec 31, 2026
NCT04174898Collaborator
MSC Infusion for Anti-aging and Regenerative Therapy
PHASE1Unknown
100 participants
Started: Apr 15, 2020 · Completed: Apr 14, 2022
NCT04107142Lead Sponsor
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour
PHASE1Unknown
10 participants
Started: Dec 1, 2019 · Completed: Mar 1, 2021
NCT02452723Lead Sponsor
A Study to Evaluate the Safety of Neural Stem Cells in Patients With Parkinson's Disease
PHASE1Unknown
12 participants
Started: Jul 31, 2016 · Completed: Jun 30, 2020
Locations (1)
Headquarters
Singapore, Singapore
Map
Loading map...